David L wrote:
Great post. Thanks for putting some easily provable facts out there. Bidenomics are hitting us personally VERY hard. Our retirement funds are depleted due to health problems in the family. We helped our disabled son buy a house ten years ago. He did a lot of improvements in that time but his heart gave out and he passed away in April. We are jumping through all the hoops and have been trying to sell it for a month now. A year ago it would have easily brought $200,000- but we are forced to lower it to about $175,00. Many people want it but cannot get financing. Darn hard to come up with a down payment when you are having trouble buying groceries, fuel, etc.
Needless to say, it really hurts to see the h**ers on OPP trying to tell us that all is well. Words cannot describe the utter disgust that I feel for such fools.
Great post. Thanks for putting some easily provab... (
show quote)
See which drugs President Biden is targeting first for Medicare price-lowering talks
BY TOM MURPHY, AMANDA SEITZ AND CHRIS MEGERIAN
Updated 10:26 AM PDT, August 29, 2023
Share
WASHINGTON (AP) — The Biden administration is targeting the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications for Medicare’s first-ever drug price negotiations as it seeks to lower medical costs for Americans.
The administration on Tuesday released a list of the 10 drugs for which prices will be negotiated directly with the manufacturer. The move is expected to cut costs for many patients, but it faces litigation from drugmakers and heavy criticism from Republican lawmakers, and it will be years before consumers notice any savings.
The effort is a centerpiece of President Joe Biden’s ree******n pitch as the Democrat seeks to show Americans he’s deserving of a second term because of the work he’s doing to lower costs for them while the country is struggling with inflation. But like the drug negotiations, many of Biden’s biggest policy moves take time to roll out, and his challenge is to persuade the public to be patient.
ADVERTISEMENT
“For many Americans, the cost of one drug is the difference between life and death, dignity and dependence, hope and fear,” Biden said in a statement. “That is why we will continue the fight to lower healthcare costs — and we will not stop until we finish the job.”
MORE HEALTH CARE COVERAGE
FILE - President Joe Biden speaks about the Inflation Reduction Act of 2022 during a ceremony on the South Lawn of the White House in Washington, Sept. 13, 2022. The one-year anniversary of the Inflation Reduction Act being signed into law is on Wednesday, Aug. 16, 2023. (AP Photo/Andrew Harnik, File)
Yes, inflation is down. No, the Inflation Reduction Act doesn’t deserve the credit
Medical charges sent to David White, who after kidney surgery got hit with a lot of extra charges, are seen at his home in Temple Hills, Md., Monday, June 26, 2023. A startling invoice that arrived in the mail may not be what you wind up paying. Errors or slow insurance payments may have inflated the total. Even if it’s accurate, financial aid or other assistance might help pare it. (AP Photo/Jacquelyn Martin)
Are you confronting a big medical bill? Attack it with a plan — and these tips
FILE - Health and Human Services Secretary Xavier Becerra speaks during a meeting with a task force on reproductive health care access in the Roosevelt Room of the White House, April 12, 2023, in Washington. The nation's top health official implored states to do more to keep lower-income residents enrolled in Medicaid as the Biden administration released figures Friday, July 28, confirming that many who had health coverage during the c****av***s p******c are now losing it. (AP Photo/Evan Vucci, File)
Paperwork problems drive surge in people losing Medicaid health coverage
Biden plans to deliver a speech on health care costs from the White House later Tuesday. He’ll be joined by Vice President Kamala Harris.
The drugs on the list announced Tuesday accounted for more than $50 billion in Medicare prescription drug costs between June 1, 2022, and May 31, according to the Centers for Medicare and Medicaid Services, or CMS.
That includes more than $16 billion on Eliquis. The drug from P****r and Bristol-Myers Squibb treats blood clots in the legs and lungs and reduces the risk of stroke in people with an irregular heartbeat called atrial fibrillation.
ADVERTISEMENT
Senior administration officials said Tuesday that the 10 drugs selected for negotiation are among the most costly to the Medicare program. They said 8.2 million people with Medicare Part D prescription drug coverage take them.
The diabetes treatments Jardiance from Eli Lilly and Co. and Boehringer Ingelheim and Januvia from Merck made the list. It also included Amgen’s autoimmune disease treatment Enbrel and Entresto from Novartis, which is used to treat heart failure.
Other drugs on the list include AstraZeneca’s diabetes and heart failure treatment Farxiga and three drugs from Johnson & Johnson: the blood thinner Xarelto, the blood cancer treatment Imbruvica and it’s biggest seller, Stelara, an IV treatment for psoriasis and other inflammatory disorders.
The list also includes several versions of Novo Nordisk’s Fiasp, a fast-acting insulin taken around meals.
The Inflation Reduction Act already caps Medicare patient out-of-pocket costs for insulin at $35 a month. An administration official said Tuesday that upper limit will hold but there could be further changes in those costs.
The announcement Tuesday is another significant step toward taming drug pricing under the Inflation Reduction Act, which was signed by Biden last year. The law also calls for a $2,000 annual cap on how much people with Medicare have to pay out of pocket for drugs starting in 2025. 2 hours ago as of 12:10 PCT 8-29-2023